All USA & Canada articles – Page 67
-
NewsState-of-the-art centre for patients with complex conditions including Lyme disease and long COVID
New state-of-the-art US centre will support patients recovering from complex chronic illnesses such as long Lyme disease and long COVID.
-
News$7 Million grant to tackle lung infections through innovative probiotic treatment
The PROTECT project seeks to combat lung infections by assembling a community of beneficial lung microbes that can outcompete harmful pathogens.
-
News$1.9M grant will help protect newborns from deadly condition
Nursing researchers will distribute training and resources to US health care providers to save infants from necrotizing enterocolitis.
-
NewsCrews sample lichens in ‘dress rehearsal’ for Martian exploration
During simulated extra-vehicular activities, Mars 160 mission specialists wearing simulated spacesuits scouted out various habitats in two Mars analog stations, seeking out lichen species growing in various microhabitats.
-
NewsFaulty ‘fight or flight’ response drives deadly C. difficile infections
The portion of our nervous systems responsible for the “fight or flight” response can shape the severity of potentially deadly C. difficile infections.
-
NewsResearchers identify signs tied to more severe cases of RSV
In a new study, researchers found an increase in NK cells in the airways of children with severe RSV as well as other alterations that suggest these cells may be contributing to disease severity.
-
NewsSelfishness mechanism points way to optimizing inhibitors that fight antibiotic resistance
Resistance can be fought by targeting bacteria that are ’selfish’ with their antibiotic resistance tools, according to a new study.
-
NewsHidden trails of marine snow can affect how the ocean stores carbon
A new study reveals never-before seen mucus ‘parachutes’ produced by microscopic marine organisms that significantly slow their sinking, putting the brakes on a process crucial for removing carbon dioxide from the atmosphere.
-
NewsLachnospiraceae could be key to successful fecal transplants
Fecal microbiota transplants are a magic bullet for patients with recurring infections from Clostridioides difficile (C. diff), but researchers are only beginning to understand why.
-
News$5.6 million grant awarded to target treatments for IBS, Crohn’s and Ulcerative colitis
An “out-of-the-box” study has been awarded a $5.6 million NIH grant to target treatments for IBS, Crohn’s, Ulcerative Colitis and more.
-
NewsViral messaging can deliver lessons on how infectious diseases spread
A new study explores a hybrid approach to understanding social networks that involves inferring not just social contacts but also the rules that govern how contagion and information spread.
-
NewsBioengineer awarded $3.4M for project to end polio
Bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against poliomyelitis into the combination vaccine that protects against five common and dangerous childhood diseases.
-
NewsHospitals that are understaffed for infection prevention and control have higher rates of infection, study says
Inadequate infection prevention and control staffing levels are associated with higher rates of healthcare-associated infections, according to a new study published today in the American Journal of Infection Control. The study, conducted by the APIC Center for Research, Practice & Innovation, summarizes a pilot project to evaluate ...
-
NewsHibernating ribosomes flip upside down in starving yeast cells
Scientists have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications.
-
NewsIn a warming world, public needs to know more about protections from mosquito-borne illnesses
Very few (15%) among the American public worry that they or their families will contract dengue or West Nile virus over the new three months, according to the latest Annenberg Public Policy Center (APPC) health knowledge survey.
-
NewsScientists discover series of SARS-CoV-2 mpro inhibitors for potential COVID-19 treatments
New research has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies.
-
NewsStudy reveals how parasites thrive by balancing specialisation with exploiting diverse species communities
A new study reveals that the prevalence of malaria-like blood parasites in birds increases with the number of species present in local bird communities. The findings indicate that parasites thrive when they can exploit a wide range of different bird species.
-
NewsTrials show common cold medication significantly improved symptoms in less than two days
Applied Biological Laboratories will present results of a clinical trial which showed Biovanta significantly improved common cold symptoms including sore throat, cough, runny nose, congestion, chills, and sneezing in less than two days.
-
NewsScientists engineer new enzyme to produce synthetic genetic material
Researchers have engineered an efficient new enzyme that can produce a synthetic genetic material called threose nucleic acid. The ability to synthesize artificial chains of TNA advances the discovery of therapeutic options to treat cancer and other diseases.
-
NewsStudy finds persistent infection could explain long COVID in some people
Researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.